| Prev Close | 129.65 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 17.91 / 178.50 |
Moderna, Inc. (MRNA)
129.65
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 395.71B |
| Market Cap | 51.30B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Rioting in the Streets, Retail Response, Trading Thoughts
Let's hope that the violence subsides, the valid voices of peaceful protesters are heard, and the lack of social distancing protocols does not lead to a resurgence in the spread of the virus.
Strong Rebound From Covid-19 Meltdown Turns Bargain Hunting Into a Challenge
A now-overbought market leaves few values available among equities.
Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
China Headline Risk, Valuation Station and a Workday Play
WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.
Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago
So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.
Perception Continues to Drive the Market
The negatives are being shaken off like a first time rider on a long-time bull which means long remains the name of the game.
Merck Is All In With a Threefold Approach to Covid-19
I've been long Merck for a long time, since way before this pandemic became part of our lives.
Floor Traders Return to NYSE, Novavax Vaccine News, Be Amphibious
The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production.
Jim Cramer: Why Is the Market Down? It's Simple
The market may be down but, once again, the decline's about the White House getting re-tough on China.
The Fed Has Our Backs, Trading Thoughts, 'Facebook Shops'
As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.
We Are Witnessing a Simultaneous Bull and Bear Market
Bull and bear markets are occurring simultaneously and that makes for good stock-picking but great difficulty if you are trying to trade the major indices.
Forget the V-Shaped Bounce, Playing Lockheed Martin, Trading Thoughts
Expect more fiscal and monetary support and don't expect a full return to previous economic activity for quite some time.
Market Winces at Vaccine News
Headlines questioning phase-one trial data by Moderna spurred late selling as this market is still a bear.
I Am a Bit of a Moderna Skeptic
So, let me get this straight. Moderna rushes to do a secondary last night even though they don't need the money yet. To me, if the vaccine works and they need to produce it in quantity, the stock will be many multiples higher than today -- and there...
Recommended Reading: The $12 Million Moderna Question
Remarkable story about the vaccine czar and Moderna .Â
Yesterday Came Suddenly
* I don't yearn or expect another yesterday, today. * Let it be... "Yesterday All my troubles seemed so far away Now it looks as though they're here to stay Oh, I believe in yesterday Suddenly I'm not half the man I used to be There's a shadow hangi...
'Risk-On' Market, Volatility and Valuation, Trading Thoughts
Watching Moderna, Microsoft and FedEx as risk continues to be a central market theme, despite Monday's rally.
Is the Market in Full Recovery Mode?
This market action has been pure sector rotation.
Jim Cramer: It's Still Better to Be Safe Than Sorry
Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.
Moderna Is a Breath of Fresh Air
I'm long this name, as I am several of the others involved. Will I add on a day like this?
Playing Bullishly... For Now
* The bears' skepticism (and cautious market positioning) coupled with their collective cynicism towards medical and scientific innovation, and the inevitability of the curve's flattening along with an "all in" Fed, have fueled the market recovery f...
Powell's Reassurance, Nvidia's Breakout Higher, Trading Thoughts
Jerome Powell hit the airwaves with some words of caution and comfort. Nvidia is running into earnings.
Mr. Market Has Been Dead Right on General Electric
GE's problem can be summarized in one sentence: The company is burning cash.
Sell Signals, 'Operation Warp Speed,' Trading Notes
Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.
Jim Cramer: Here's the Cramer Covid-19 Index Top 10 Names and Their Performance
There are simply an immense number of health and technology and safety companies coupled with businesses that thrive when you have to stay home.
Moderna's Rally Is Not Over: Our Latest Trading Strategy
Thursday's rally was sparked by news that Moderna's Covid-19 vaccine candidate is moving to Phase II testing.
Jim Cramer: The Hope Is Real
I get this rally -- it's based on more than a breaking branch this time, but there are still many uncertainties.
Want to Know Why I'm Not Selling Moderna?
I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.
Trading Volume, Late Selloffs, Peloton's Run Higher
As Treasury heads for longer-dated issuance and names like PTON run higher on earnings, selloffs late in the trading day continue.
Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine
PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.
